技术和操作技巧都非常重要。最近,有很多新型设备出现,日本医生精通于这些设备的应用。但是,技术上有一定局限性,基于技术本身,医生只能达到特定的水平。最终,操作技巧和临床实践是最重要的。对于CTO领域的技术来讲,新型CTO导丝的研发非常重要。
International Circulation: According an article published in the JACC in February by Galassi et al., there is a transient impairment of vasomotion function after successful chronic total occlusion recanalization. Could you comment on how this might be avoided by proper selection of stent size?
Dr. Kinoshita: It is difficult to avoid. In many cases of diffuse CTO lesion, we often observe the difference of vessel diameter between after procedure and the follow-up. As you know, impairment of vasomotion is a big issue in stent implantation, especially because of the underestimation of stent size. We sometimes confuse which stent size is suitable for that lesion. In such a situation, information from IVUS will be important. Usually, more than 80% of interventional cardiologists in Japan use the IVUS catheter during a procedure. From IVUS images, we can get a lot of informations, such as vessel size and plaque composition. IVUS catheters help us chose the proper stent size. I usually decide stent size in this lesion by a combination of information from IVUS and my own practice.
《国际循环》:根据JACC杂志2月由Galassi等发表的一篇论文,CTO成功再通后会有短暂的血管运动功能障碍。能否介绍下如何通过正确地选择支架的尺寸来避免这一问题?
Kinoshita教授:短暂的血管功能障碍难以避免。对于很多有弥漫CTO病变的病例,我们经常会发现介入操作之后和随访的血管直径存在差别。正如你刚才所提到的,血管运动功能障碍是支架置入所面临的一个大问题,在对支架大小估计不足的情况下,尤其会发生这一问题。有些时候,我们对哪个支架大小适合病变而感到困惑。此时,IVUS的信息具有重要意义。通常来讲,日本超过80%的介入心脏病医生在操作中会使用IVUS。我们从IVUS影像可得到很多信息,包括血管大小和斑块构成。IVUS有助于我们选择合适的支架大小。我通常综合考虑IVUS的信息和我自己的经验来确定病变合适的支架大小。